Cyclophosphamide Induces Hepatorenal Toxicity and Attenuation by 5-fluorouracil in Male Albino Rats

Table 1.

Serum total protein, albumin, and globulinconcentrations of rats treated with cyclophosphamide and/or 5-fluorouracil

Groups

Parameters

Control

CPA

5-FU

CPA – 5-FU

Mean±SE

Mean±SE

Mean±SE

Mean±SE

Serum total protein concentration (g/dl)

10.01±0.73 bc

7.93±0.26 acd

9.32±0.36 ab

9.67±0.58 b

Serum albumin concentration (g/dl)

4.23±0.15 bd

3.39±0.61 acd

4.54±0.35 b

4.40±0.13 ab

Serum globulin concentration (g/dl)

5.82±0.17 bd

3.30±0.37 acd

4.96±0.40 ab

5.22±0.57 b

Significance at P > 0.05. CPA: cyclophosphamide; 5-FU: Fluorouracil, a Comparison of control and other groups; b Comparison of CPA and other groups; c Comparison of 5-FU and other groups; d Comparison of CPA – 5-FU and other groups

Significance at P > 0.05. CPA: cyclophosphamide; 5-FU: Fluorouracil, a Comparison of control and other groups; b Comparison of CPA and other groups; c Comparison of 5-FU and other groups; d Comparison of CPA – 5-FU and other groups